The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular Is BPC 157 Banned? Oral vs. Injectable Forms Explained